Apnimed, Inc.

NasdaqGM:APMD Stock Report

Market Cap: US$570.0m

Apnimed Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Kevin Lind

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure3.2yrs
Board average tenure3.4yrs

Recent management updates

No updates

Recent updates


CEO

Kevin Lind (50 yo)

less than a year
Tenure

Mr. Kevin R. Lind is Chief Executive Officer of Apnimed, Inc. from June 2, 2026 and serves as its Director from March 2025. Mr. Lind served as Non-Executive Chairman of the Board of Apnimed, Inc. since Mar...


Leadership Team

NamePositionTenureCompensationOwnership
Kevin Lind
CEO & Directorless than a yearno datano data
Lawrence Miller
Founder & Vice Chair of the Board8.5yrsno data1.18%
$ 6.7m
Dennis Molnar
President & COO7.9yrsno data0.15%
$ 870.2k
Luigi Montemurro
Co-Founder & Chief Scientific Officer5.3yrsno datano data
Michael Kelly
Chief Financial Officerless than a yearno datano data
Leila Sylvain
Senior Manager of Administration3.9yrsno datano data
Steven Spector
Chief Legal Officer & Head of Corporate Affairsless than a yearno datano data
Jennifer Patterson
Senior Vice President of Human Resourcesless than a yearno datano data
John Cronin
Chief Medical Officer3.8yrsno datano data
Sean Johnston
Consulting Head of CMC3.5yrsno datano data
John Yee
Senior Vice President of Medical Affairs2.8yrsno datano data
Graham Goodrich
Chief Commercial Officer2.5yrsno datano data
3.2yrs
Average Tenure
57.5yo
Average Age

Experienced Management: APMD's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kevin Lind
CEO & Director1.3yrsno datano data
Lawrence Miller
Founder & Vice Chair of the Board8.5yrsno data1.18%
$ 6.7m
Paul Sekhri
Independent Chair of the Boardless than a yearno datano data
Gary Sender
Independent Director1.8yrsno data0%
$ 0
Chris Dimitropoulos
Independent Director3.5yrsno datano data
Joseph Avellone
Independent Director9yrsno data0%
$ 0
Douglas Kirsch
Member of Medical Advisory Boardno datano datano data
Isaac Cheng
Independent Director4.2yrsno datano data
Paul Fonteyne
Independent Director2.8yrsno data0%
$ 0
François Beaubien
Independent Director3.4yrsno datano data
Danny Eckert
Member of Medical Advisory Boardno datano datano data
Susan Redline
Member of Medical Advisory Boardno datano datano data
3.4yrs
Average Tenure
64.5yo
Average Age

Experienced Board: APMD's board of directors are considered experienced (3.4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/31 10:19
End of Day Share Price 2026/07/30 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Apnimed, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.